Spots Global Cancer Trial Database for secondary hyperparathyroidism(shpt)
Every month we try and update this database with for secondary hyperparathyroidism(shpt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
